A Holistic Strategy to Characterize the In Vivo Stability of Novel Modalities Using Affinity Capture Coupled to LC-MS or CE-Based Methods

Speaker Presentation Wu Cong, Genentech, a Member of the Roche Group, 2020     
A Holistic Strategy to Characterize the In Vivo Stability of Novel Modalities Using Affinity Capture Coupled to LC-MS or CE-Based Methods